重症水痘-带状疱疹病毒肺炎:一项多中心队列研究
该多中心观察性研究纳入1996年1月至2015年1月29个ICU收治的102例水痘-带状疱疹病毒社区获得性肺炎(VZV-CAP)患者,患者年轻(年龄39岁,四分位距32-51),52%免疫功能低下。半数患者在入ICU后1(1-2)天内接受机械通气,80%符合ARDS。第1天SOFA评分、入ICU时氧流量和早期细菌合并感染与需要机械通气独立相关。ICU病死率17%,住院病死率24%。与60例匹配的无激素对照相比,接受糖皮质激素者机械通气时间和ICU住院时间更长,住院病死率相似,但ICU获得性感染更多。
要点
- 102例重症VZV-CAP患者中52%免疫功能低下,年龄39岁(四分位距32-51),入ICU时除4例外均有典型皮疹。
- 半数患者在入ICU后1(1-2)天内接受机械通气,PaO2/FiO2为150(80-284),其中80%符合ARDS。
- 第1天SOFA评分(OR 1.90,95%CI 1.33-2.70;p<0.001)、入ICU时氧流量(OR 1.25,95%CI 1.08-1.45;p=0.004)和早期细菌合并感染(OR 14.94,95%CI 2.00-111.8;p=0.009)与需要机械通气独立相关。
- ICU病死率17%,住院病死率24%;机械通气时间14(7-21)天。
- 与60例匹配的无激素对照相比,接受糖皮质激素者机械通气时间更长、ICU住院时间更长、ICU获得性感染更多,住院病死率相似。
适用人群与场景
- 1996年1月至2015年1月29个ICU收治的成人VZV-CAP患者,共102例,年龄39岁(四分位距32-51),53例(52%)免疫功能低下。
- 入ICU时除4例外均出现典型皮肤皮疹;呼吸症状出现至入ICU时间为2(1-3)天。
处置流程与药物剂量
- 所有患者均接受阿昔洛韦治疗;10例接受糖皮质激素辅助治疗。
- 半数患者在入ICU后1(1-2)天内接受机械通气,机械通气时间14(7-21)天。
研究设计与关键结果
- 多中心观察性研究,纳入29个ICU的102例VZV-CAP患者,主要观察临床特征、管理和结局。
- 第1天SOFA评分(OR 1.90,95%CI 1.33-2.70;p<0.001)、入ICU时氧流量(OR 1.25,95%CI 1.08-1.45;p=0.004)和早期细菌合并感染(OR 14.94,95%CI 2.00-111.8;p=0.009)与需要机械通气独立相关。
- ICU病死率17%,住院病死率24%;机械通气时间14(7-21)天;接受机械通气者PaO2/FiO2为150(80-284),80%符合ARDS。
- 与60例匹配的无激素对照相比,接受糖皮质激素者机械通气时间更长、ICU住院时间更长、住院病死率相似,但ICU获得性感染更多。
证据类型、等级与局限
- 证据类型:多中心观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 重症VZV-CAP可导致急性肺损伤,伴有显著的并发症和病死率;作者认为糖皮质激素治疗未影响病死率,但增加重叠感染风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pneumonia is a dreaded complication of varicella-zoster virus (VZV) infection in adults; however, the data are limited. Our objective was to investigate the clinical features, management, and outcomes of critically ill patients with VZV-related community-acquired pneumonia (VZV-CAP).
METHODS: This was an observational study of patients with VZV-CAP admitted to 29 intensive care units (ICUs) from January 1996 to January 2015.
RESULTS: One hundred and two patients with VZV-CAP were included. Patients were young (age 39 years (interquartile range 32-51)) and 53 (52%) were immunocompromised. Time since respiratory symptom onset was 2 (1-3) days. There was a seasonal distribution of the disease, with more cases during spring and winter time. All but four patients presented with typical skin rash on ICU admission. Half the patients received mechanical ventilation within 1 (1-2) day following ICU admission (the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) = 150 (80-284), 80% with acute respiratory distress syndrome (ARDS)). Sequential Organ Failure Assessment (SOFA) score on day 1 (odds ratio (OR) 1.90 (1.33-2.70); p < 0.001), oxygen flow at ICU admission (OR 1.25 (1.08-1.45); p = 0.004), and early bacterial co-infection (OR 14.94 (2.00-111.8); p = 0.009) were independently associated with the need for mechanical ventilation. Duration of mechanical ventilation was 14 (7-21) days. ICU and hospital mortality rates were 17% and 24%, respectively. All patients were treated with aciclovir and 10 received adjunctive therapy with steroids. Compared to 60 matched steroid-free controls, patients treated with steroids had a longer mechanical ventilation duration, ICU length of stay, and a similar hospital mortality, but experienced more ICU-acquired infections.
CONCLUSIONS: Severe VZV-CAP is responsible for an acute pulmonary involvement associated with a significant morbidity and mortality. Steroid therapy did not influence mortality, but increased the risk of superinfection.
参考来源
- Mirouse A, Vignon P, Piron P, et al. Severe varicella-zoster virus pneumonia: a multicenter cohort study. Crit Care. 2017. PMID: 28592328. doi:10.1186/s13054-017-1731-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。